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Regulation of MMP-2 Gene Transcription in Dermal
Wounds
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Alexandra Alfonso-Jaume3, Uwe Klinge2,4, David H. Lovett5 and Peter R. Mertens6
Matrix metalloproteinase-2 (MMP-2, gelatinase A) plays an essential role in angiogenesis, inflammation, and
fibrosis. These processes are critical for wound healing and accordingly elevated levels of MMP-2 expression
have been detected after skin injury. Our goal was to investigate the transcriptional activation of the MMP-2
gene in a model of skin injury by using two different MMP-2/LacZ-reporter mice. Upon skin injury MMP-2
expression was upregulated, whereas tissue from normal skin stained negative except for occasional
macrophages, sweat glands, and hair follicles. Skin injury also activated MMP-2 proteolytic activity and
reporter gene expression. We demonstrate that MMP-2 regulatory sequences 1686/þ 423 drive appropriate
injury-induced MMP-2-promoter activation. Reporter gene expression was predominantly detectable in
endothelial cells and in macrophages. Deletion of the 50 responsive element, denoted RE-1, residing at
1241/þ 423 bp of the regulatory sequence led to abrogated MMP-2 transcription in vivo. The findings define a
crucial role for the enhancer element RE-1 in injury-induced MMP-2 transcription of the skin.
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INTRODUCTION
Tissue injury initiates an inflammatory response, tissue
formation, and remodelling to reconstruct the wounded area.
Genetically modified animal models have helped to define
the roles of many key molecules in these processes (Werner
and Grose, 2003; Grose and Werner, 2004). As such, matrix
metalloproteinases (MMPs) have been identified as key
enzymes that regulate wound healing and matrix remodelling
(Kato et al., 2001a). These zinc-dependent enzymes operate
by hydrolyzing components of the extracellular matrix and by
directly affecting cellular phenotypes, proliferation rates, and
the inflammatory reaction (Marti et al., 1994; Turck et al.,
1996). Inhibition of MMPs by a broad MMP inhibitor
(GM6001) prevents the MMP-related promotion of wound
healing via a complex mechanism involving stimulation of
angiogenesis and inhibition of inflammation (Jackson et al.,
2005). In diseases such as arthritis (Ishikawa et al., 2005),
cancer (Mandal et al., 2003), atheroma (Wu and Li, 2006),
and tissue ulceration (Agren, 1994), MMP-2 (72 kDa col-
lagenase, gelatinase A) enzymatic activities are upregulated
at the sites of inflammation, fibrosis, and angiogenesis. In
MMP-2-deficient mice, impaired neoangiogenesis was
observed in the presence of tumor cells (Itoh et al., 1998)
or in experimental inflammation-associated corneal neovas-
cularization (Kato et al., 2001a; Samolov et al., 2005). MMP-
2 expression is absent in healthy skin except for occasional
macrophages, sweat glands, and hair follicles (Agren, 1994;
Vaisanen et al., 1996). Mice with targeted deletion of the
MMP-2 gene exhibit only slight disturbances of growth
indicating that lack of MMP-2 is not critical under physio-
logical conditions. However, these mice demonstrated
diminished angiogenesis after injury (Kato et al., 2001b).
The extent of MMP-2 expression and enzymatic activity is
regulated at the transcriptional, translational, and posttransla-
tional levels (Overall and Lopez-Otin, 2002). Regulatory
elements spanning the proximal 1686 bp of the MMP-2 gene
relative to the translational start have been shown to govern
MMP-2 gene transcription (Frisch and Morisaki, 1990;
Harendza et al., 1995; Mertens et al., 1997, 1998, 2002;
Harendza et al., 2000). A strong enhancer element, denoted
response element-1 (RE-1), is located at 1322/1282 bp of
the rat gene (Harendza et al., 1995) that is evolutionarily
conserved and is similarly operative within the human gene
at 1657/1619 bp relative to the transcription start site
(Mertens et al., 1999). At least five distinct transcription
factors may, mostly cooperatively, bind to the RE-1.
Transcriptional regulation of MMP-2 synthesis in vivo is
similarly coordinated by distinct subsets of transcription
factors, as shown by a recent study on ischemia of the limb
(Lee et al., 2005).
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Given these findings that support the pivotal role of MMP-
2 enzyme in wound healing and inflammatory response, we
set out to unravel the molecular mechanisms that govern
MMP-2 gene transcription in vivo. A wound-healing model
was established in transgenic reporter mice harboring a
b-galactosidase-reporter gene (LacZ), driven by defined
regulatory sequences of the MMP-2 gene. Furthermore, the
spatial and temporal transcriptional regulation of the MMP-2
gene was analyzed at the cellular level and compared with
protein synthesis and enzymatic activity.
RESULTS
MMP-2 protein expression and MMP proteolytic activity is
enhanced in healing wounds
To determine patterns of MMP-2 expression in healthy skin
and after full-thickness dermal incision, immunohistochem-
istry was performed with MMP-2-specific antibodies. In
healthy skin, MMP-2 protein expression was detected in the
epidermal layer and in hair follicles (Figure 1a). Quantitative
analysis of MMP-2-positive cells demonstrated that MMP-2
protein expression was significantly enhanced on days 7, 21,
and 90 after injury compared with non-incised skin (Figure
1b and c). In addition to macrophages and fibroblasts, vessels
within the scar tissue exhibited MMP-2 positivity (Figure 1d).
To corroborate MMP-2 proteolytic activity with expression
levels, results obtained by immunohistochemistry were
compared with in situ zymograms. Although basal levels of
MMP-2 protein expression were detected in healthy skin,
proteolytic activity was nearly absent in in situ zymograms
(Figure 2a and c). After injury, gelatinolytic activity could be
visualized (translucent areas in Figure 2b). Semiquantitative
analysis of in situ zymography revealed enhanced MMP
proteolytic activity at all time points in healing wounds. No
gelatinolytic activity was detected when MMPs were blocked
by a synthetic inhibitor (Figure 2d). In summary, MMP-2
protein expression and proteolytic activity are upregulated in
healing wounds.
MMP-2 transcription is induced via regulatory sequences
1686/þ 423 in healing wounds
It is known that MMP-2 protein synthesis is regulated at the
level of transcription as well as translation (Corcoran et al.,
1996). Distinct regulatory elements within the MMP-2 gene
promoter have been mapped previously, as outlined in the
Introduction. In vitro, these regulatory elements confer cell-
specific gene transcription. Transcriptional activity conferred
by sequences 1686/þ 423 was assessed in F8 animals
(Figure 3a). Control-staining was performed by omitting the
primary antibody (Figure 3b). Figure 3c illustrates dermal
MMP-2-reporter gene expression in F8 mice 7 days after
injury: Within the scar tissue, b-galactosidase-reporter gene
expression was significantly enhanced. In healthy skin,
b-galactosidase staining was restricted to the epidermal layer
and hair follicles. The reporter-gene expression driven by
MMP-2 regulatory sequences 1686/þ413 was upregulated
over time in F8 mice (Figure 4a). Furthermore, b-galactosi-
dase staining was obviously enhanced in F8 animals when
compared with F8del animals with selectively deleted
sequences 1686/þ1241 (Figure 4a and b). These differ-
ences in b-galactosidase expression patterns could be
observed at all time points. The decreased reporter-gene
expression in F8del mice indicates that RE-1 acts as an
a b
d
c 60
50
40
30
20
10
0
Day 7 Day 21 Day 90
Skin
50 m
25 m
%
 M
M
P-
2 
po
sit
ive
 c
e
lls
/0
.0
1 
m
m
2
Figure 1. MMP-2 protein expression is enhanced in healing wounds. Immunohistochemistry for MMP-2 protein was performed and analyzed quantitatively
for time points 7, 21, and 90 days. (a) MMP-2 protein expression in healthy skin is detectable within the epidermal layer, hair follicles, and in several cells
interspersed in the subepidermal layer. Morphologically, these cells correspond to macrophages and fibroblasts. (b) MMP-2 protein expression is strongly
enhanced 7 days after full dermal-skin incision. Bar¼ 50 mm. (c) Morphometric analyses revealed significantly enhanced MMP-2 protein expression at all time
points in healing wounds when compared with healthy skin. Tissue areas of 0.01 mm2 were analyzed in F8 and F8del transgenic mice (n¼ 12 at each time
point). Data are represented as means 7SEM. Differences between both strains were not detected (data not presented). (d) MMP-2 expression in vessel walls.
Section of (b) is presented.
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enhancer element of MMP-2 transcription in healing wounds
in vivo.
Localization of MMP-2 transcription
By means of b-galactosidase immunofluorescence, the
distribution of MMP-2 transcription within the tissue speci-
mens was further analyzed. As seen by immunohistochem-
istry, basal staining for b-galactosidase was detectable in hair
follicles, within the epidermis and occasionally in fibroblasts
and residential macrophages in non-incised skin of F8 mice
(Figure 5a). After injury, cells with intense b-galactosidase
staining were evident (Figure 5b, white arrows). These cells
were absent in F8del mice, whereas basal staining of
b-galactosidase in hair follicles and within the epidermis still
occurs (Figure 5c). Immunofluorescence costaining for
b-galactosidase and CD68 or vWF revealed that MMP-2
regulatory sequence 1686/þ413, which includes the RE-1,
is required for MMP-2 transcription in macrophages and
vascular endothelial cells, respectively (Figure 6a and b).
DISCUSSION
In this report, we provide insights into the transcriptional
regulation of MMP-2 expression during the course of dermal-
wound healing. We show that MMP-2 expression and
proteolytic activity is upregulated in the subepidermal layer
following skin injury. The results obtained by immuno-
histochemistry indicate an induction of MMP-2 protein
expression over time, whereas MMP proteolytic activities
were highest on day 7 and declined over time. It is likely that
MMP proteolytic activity is subjected to regulatory interac-
tion with tissue inhibitor of metalloproteinases or micro-
tubule–MMPs. Ongoing MMP-2 protein synthesis provides a
pool of latent enzyme ready for subsequent activation.
To date, several therapeutic approaches have been taken
to chemically block MMP activities at the protein level, but
clinical trials with variably selective MMP inhibitors have
been mostly unsuccessful. Our findings indicate that
decreased transcriptional activity occurs following partial
deletion of the RE-1. These data indicate that the RE-1 is an
important cis-acting factor in injury related dermal-wound
healing. In this regard, selective inactivation of MMP-2-
specific regulatory elements may be more promising. Such an
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Figure 2. MMP proteolytic activity is enhanced in healing wounds. In situ zymography was performed and analyzed quantitatively for 7, 21, and 90 days.
Translucent areas correspond to gelatinolytic activity. (a) Absence of proteolytic activity in healthy skin. (b) Areas of proteolytic activity 7 days after dermal
incision, indicated by black arrows. (c) Semiquantitative analysis of in situ zymography reveals enhanced MMP proteolytic activity at all time points in healing
wounds when compared with healthy skin. Tissue areas were analyzed in F8 and F8del transgenic mice and summarized (n¼12 at each time point). Data are
represented as means 7SEM. Differences between both strains were not detected (data not presented). (d) Control experiments with MMP-inhibitor 1.
10-phenanthroline were performed with specimen on day 7 after dermal incision. Bar¼ 50 mm.
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Figure 3. MMP-2 transcription is induced via regulatory sequences
1686/þ 423 in healing wounds. Immunohistochemistry for b-galactosidase
was performed in F8 mice. (a) Schematic depiction of transgene introduced
into F8 mice. LacZ-reporter gene is driven by MMP-2 regulatory sequences
1686/þ413 including the RE-1. (b) Control stainings were performed by
omitting the primary anti-b-galactosidase antibody. (c) b-galactosidase-
reporter gene expression in F8 mice was significantly enhanced within the
scar tissue. In contrast, b-galactosidase staining was restricted to the
epidermal layer and hair follicles in healthy skin. A representative image
taken with specimen from day 7 following dermal incision is shown.
Bar¼200 mm.
1764 Journal of Investigative Dermatology (2007), Volume 127
P Lynen Jansen et al.
Regulation of MMP-2 Gene Transcription in Dermal Wounds
approach was recently realized by Miyake et al. (2006), who
successfully prevented the development of arterial aneurysm
via blockage of MMP-2 transcription by NF-kB/ets1 oligo-
nucleotide decoys in rabbits. The identification of RE-1 as a
key regulatory element in MMP-2 transcription following
dermal injury may provide a similar basis for the application
of double-stranded oligodeoxynucleotides that are directed
against one or even more specific cis-elements.
Moreover, our data indicate that MMP-2 gene transcrip-
tion was cell specifically regulated. We identified sequences
1686/1241 as critical for enhancement of MMP-2
transcription in macrophages and vascular endothelial cells
in vivo. It is known that macrophages are strongly involved in
MMP-2 expression and gene regulation at sites of inflamma-
tion. In vivo, Eerola et al. observed a direct relation between
MMP-2 gene activation and porcine posttransplant fibrotic
reaction (Eerola et al., 2005).
Modulation of MMP-2 expression might represent a novel
approach for reorganizing cell–cell interactions with the aim
to optimize wound healing or inflammation-associated
diseases. Potential therapeutic targets are the transcription
factors, for example Y-box protein-1 (YB-1), that bind to the
RE-1 and cell-specifically trans-activates as well as trans-
represses the MMP-2 promoter (Mertens et al., 1997).
Interference with MMP-2 transcription may provide for cell-
specific fine-tuning of the MMP-promoter transcriptional
regulation. In conclusion, our findings highlight the complex-
ity of MMP-2 gene regulation following dermal wounding, a
key molecule for matrix remodelling. The established
transgenic mice serve as useful models for further in vivo
F8
a
b
Day 7 Day 21 Day 90
F8del
Response element 1
−1686
−1241
+ 423
+ 423
Lacz
Lacz
100 m
Figure 4. The MMP-2-regulatory sequences 1686/1241 are critically involved in conferring MMP-2 transcription in healing wounds.
Immunohistochemical staining for b-galactosidase in F8 mice was compared with staining in F8del mice for time points 7, 21, and 90 days. (a) Reporter gene
expression driven by MMP-2 regulatory sequences 1686/þ 413 is induced over time in F8 mice. (b) The reporter gene expression is significantly reduced after
deletion of regulatory sequences 1686/1241 at all time points in F8del mice. Bar¼ 100mm.
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Figure 5. Localization of MMP-2 transcription is dependent on RE-1.
Immunofluorescence staining for b-galactosidase (red) was performed. Nuclei
were detected by DAPI staining (blue). (a) In healthy skin, staining for
b-galactosidase was predominantly detected in hair follicles (F), within the
epidermis (E) and occasionally in fibroblasts and residential macrophages
within the dermis. (b) After dermal incision, areas of intense b-galactosidase
expression within the dermis were detectable in F8 mice (white arrows).
(c) Areas of intense b-galactosidase staining within the dermis were absent in
F8del mice, whereas b-galactosidase staining was still detectable in hair
follicles (F) and within the epidermis (E). Bar¼ 100mm.
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Figure 6. MMP-2-regulatory sequences 1686/þ 413, including RE-1, drive
MMP-2 transcription in macophages and vascular endothelial cells.
Immunofluorescence costaining of b-galactosidase and CD68 or vWF in F8
mice. (a) CD68 (red) positive macrophages exhibited b-galactosidase (green)
costaining; (b) vWF (red) positive vascular endothelial cells exhibited
b-galactosidase (green) costaining. Bar¼ 50 mm.
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testing of ‘‘optimized’’ wound healing and neoangiogenesis
with the aim to disrupt and/or enhance MMP-2 transcription.
MATERIALS AND METHODS
MMP-2/LacZ transgenic mice model
The two mice strains used as animal models have been described in
detail (Lee et al., 2005). In brief, mouse strain F8 harbor a
aˆ-galactosidase-reporter gene (LacZ) under control of MMP-2
regulatory sequences 1686/þ 423 that extend to the middle of the
second exon. To determine the significance of the RE-1 that extends
from1282 to1322 bp, F8del mice were utilized that harbor MMP-
2-regulatory sequence 1241/þ 423, excluding the RE-1.
Study design and surgery
The mice were fixed in the supine position. Full-thickness dermal
incisions extending over 1.5 cm were performed 1 cm bilateral of the
abdominal midline in 18 animals of each strain. The surgical
procedure was performed under sterile conditions and general
anesthesia by intramuscular administration of ketamine (ketamin
10%; Sanofi-Ceva, Du¨sseldorf, Germany) and xylazine (rompun 2%;
Bayer, Leverkusen, Germany). After 7, 21, and 90 days of
implantation, animals were killed by isoflurane asphyxation and
decapitation. Tissue was harvested, split, and either fixed in 10%
formalin for morphological analysis or quick-frozen and stored at
801C for activity assays. All animals received human care in
accordance with the guidelines of the ‘‘Deutsche Tierschutzgesetz’’
(50.203.2-AC 46, 38/02) and the National Institutes of Health
guidelines for the use of laboratory animals.
Histomorphological and immunohistochemical analyses
Histological and immunohistochemical investigations were per-
formed on paraffin-embedded 3-mm sections using peroxidase-
conjugated, affinity-isolated Igs. All sections were routinely stained
with hematoxylin and eosin and were processed at the same time to
reduce internal staining variations or histomorphological studies.
Immunohistochemistry was performed using the avidin–biotin
complex and diaminobenzidine as chromogen. To detect cells with
MMP-2-promoter activity, sections were incubated with monoclonal
anti-b-galactosidase antibody (Europa, Cambridge, UK, 1:1700)
followed by biotinylated rabbit anti-mouse IgG (Dako, Denmark,
1:300). Immunohistochemical staining was explored for MMP-2
(polyclonal rabbit, Biomol, Hamburg, 1:1000), a-smooth muscle
actin (polyclonal rabbit, Abcam, Cambridge, UK, 1:300), CD68
(polyclonal rabbit, Santa Cruz, USA, 1:100), and vWF (polyclonal,
Dako, Denmark, 1:400) followed by incubation with goat anti-rabbit
IgG antibody (Dako, Denmark, 1:500). Coexpression of b-galacto-
sidase with MMP-2, a-smooth muscle actin, CD68, and vWF was
determined by immunofluorescence using goat anti-mouse, donkey
anti-goat, and goat anti-rabbit secondary antibodies (Alexa Fluor
488, Molecular probes, Eugene, OR). Semiquantitative analyses of
immunohistochemical staining (area 100 100mm, 400-fold mag-
nification) were performed with digital imaging analyzing software
(Image-Pro Plus. Media Cybernetics, Silver Spring, MD). Control
stainings were performed by omitting the primary antibodies.
Zymography
Serial-frozen sections were placed on MMP in situ ZymoFilms
composed of a 7-mm-thick layer of gelatin on a polyester base (Wako
Chemicals, Neuss, Germany) or MMP-PT in situ ZymoFilm, which
contains the MMP inhibitor 1.10-phenanthroline. Films were
incubated at 371C for 24 hours and stained with Biebrich Scarlet
(Wako Chemical Industries, Japan). Gelatin digestion is visualized
as transparency. Results obtained by comparison of both films
indicate localization of MMP-specific proteolytic activity. Two
blinded observers evaluated the gelatinolytic activity according to
a scoring system (: negative; þ : weak; þ þ : moderate; þ þ þ :
strong) in six independent tissue samples for each subgroup and time
point.
Statistics
The study was performed as balanced incomplete block design. Data
were organized according to time, strain, and side. Differences
between the groups were evaluated for statistical significance by
analysis of variance describing the effect of strain, day, strain day,
and side. Data were described as mean values 7SD.
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